Can virtual reality reduce anxiety and pain in dental patients?

GRADE Rating:

Commentary

The fear of pain and dental anxiety are widely recognised as factors that can negatively impact the quality of care and may result in patients discontinuing treatment1. This avoidance of dental care contributes to poor oral health, including decay and tooth loss. Dentists often face challenges in effectively managing patients’ fear and anxiety2.

Several approaches have been used to manage dental pain and anxiety, including techniques such as guided imagery, hypnotherapy and acupuncture. Additionally, strategies such as enhancing patient control, voice control, behaviour shaping, the ‘tell-show-do’ technique, and distraction have also proven effective in alleviating anxiety and dental pain3.

One known distraction technique, virtual reality (VR), aims to immerse users in a three-dimensional environment, disconnecting them from their immediate surroundings4,5. Research on the use of VR in dental settings has been inconsistent and primarily focused on children. This quantitative systematic review and meta-analysis examined the impact of VR on reducing dental anxiety and pain across all age groups and dental conditions6.

The review was conducted with a strong methodological framework. It reports a clear aim and research question, employs a PICOS-guided search strategy, and presents a detailed PRISMA flow diagram7. This enhances the reliability of findings and allows the reader to interpret results with a high degree of confidence. The search encompassed two reputable primary databases, PubMed and the Cochrane Library. However, extending the search to include additional databases and grey literature could have further strengthened the review and reduced the risk of publication bias. Positively, the inclusion criteria included all patient groups, regardless of age, gender, or race, and included randomised controlled trials (RCTs) of various designs, including parallel, crossover, and split-mouth trials. Other study designs, for example cohort studies and case control studies, would not have been suitable to answer the research question and provide low quality evidence. The review was not limited by publication date. VR is likely to have advanced in recent years, and recent studies may not be comparable to older studies. A meta-analysis could have been completed grouping publication date on effect. Only studies published in English were included, and there is a risk that relevant studies published in other languages or using different terminologies were not identified.

Data extraction was performed by two independent researchers. The inclusion of a third reviewer could have helped resolve any disagreements and reduced the risk of subjective bias.

The 27 studies included in the review were conducted across various countries and published in reputable journals. Notably, 70% of the studies focused on the effects of VR on children and there was a ‘predominance of female gender’. This reduces generalisability of the review findings. Positively, the effects of VR were explored across a wide range of dental procedures, including the extraction of primary/permanent teeth, pulp therapy, restorative treatment and Inferior Dental Blocks. This increases external validity of the review.

A strength of this systematic review is the authors application of the GRADE assessment tool8, which provides guidance for how much confidence can be placed on findings. Additionally, two independent reviewers assessed bias using the Risk of Bias 2 tool9. The review authors are transparent in noting that all included studies had a high risk of bias, citing issues such as inadequate concealment of allocation sequences and deviations from the intended interventions. Notably, none of the studies employed double blinding, and 17 studies lacked pre-registered protocols. The quality of evidence was rated low to moderate. Appropriate statistical methods were used to assess heterogeneity, which was found to be high. Adopting a core-outcome set for dental pain and anxiety could support reduced heterogeneity in future reviews.

The high heterogeneity, low to moderate quality of evidence, and high risk of bias in the included studies limits the validity of results. The authors state that the results should be ‘interpreted with caution’.

This review provides valuable insights into the potential use of VR in dental settings, particularly for reducing dental anxiety and pain. It is important for researchers, especially those conducting RCTs, to minimise bias and control for confounding variables. Well-conducted research is needed to build upon these findings and strengthen the evidence base for VR use in dentistry.

Related Articles

Experts consensus on management of tooth luxation and avulsion

Traumatic dental injuries (TDIs) of teeth occur frequently in children and adolescents. TDIs that impact the periodontal tissues and alveolar tissue can be classified into concussion, subluxation, extrusive luxation, intrusive luxation, lateral luxation, and avulsion. In these TDIs, management of injured soft tissue, mainly periodontal ligament, and dental pulp, is crucial in maintaining the function and longevity of the injured teeth. Factors that need to be considered for management in laxation injuries include the maturation stage of the traumatic teeth, mobility, direction of displacement, distance of displacement, and whether there are alveolar fractures. In avulsion, the maturation stage of the permanent tooth, the out-socket time, storage media/condition of the avulsed tooth, and management of the PDL should also be considered. Especially, in this review, we have subdivided the immature tooth into the adolescent tooth (Nolla stage 9) and the very young tooth (Nolla stage 8 and below). This consensus paper aimed to discuss the impacts of those factors on the trauma management and prognosis of TDI to provide a streamlined guide for clinicians from clinical evaluation, diagnostic process, management plan decision, follow-up, and orthodontic treatment for tooth luxation and avulsion injuries.

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

X-linked hypophosphataemia (XLH) is a rare metabolic bone disorder caused by pathogenic variants in the PHEX gene, which is predominantly expressed in osteoblasts, osteocytes and odontoblasts. XLH is characterized by increased synthesis of the bone-derived phosphaturic hormone fibroblast growth factor 23 (FGF23), which results in renal phosphate wasting with consecutive hypophosphataemia, rickets, osteomalacia, disproportionate short stature, oral manifestations, pseudofractures, craniosynostosis, enthesopathies and osteoarthritis. Patients with XLH should be provided with multidisciplinary care organized by a metabolic bone expert. Historically, these patients were treated with frequent doses of oral phosphate supplements and active vitamin D, which was of limited efficiency and associated with adverse effects. However, the management of XLH has evolved in the past few years owing to the availability of burosumab, a fully humanized monoclonal antibody that neutralizes circulating FGF23. Here, we provide updated clinical practice recommendations for the diagnosis and management of XLH to improve outcomes and quality of life in these patients.

Dopamine in the tail of the striatum facilitates avoidance in threat–reward conflicts

Responding appropriately to potential threats before they materialize is critical to avoiding disastrous outcomes. Here we examine how threat-coping behavior is regulated by the tail of the striatum (TS) and its dopamine input. Mice were presented with a potential threat (a moving object) while pursuing rewards. Initially, the mice failed to obtain rewards but gradually improved in later trials. We found that dopamine in TS promoted avoidance of the threat, even at the expense of reward acquisition. Furthermore, the activity of dopamine D1 receptor-expressing neurons promoted threat avoidance and prediction. In contrast, D2 neurons suppressed threat avoidance and facilitated overcoming the potential threat. Dopamine axon activation in TS not only potentiated the responses of dopamine D1 receptor-expressing neurons to novel sensory stimuli but also boosted them acutely. These results demonstrate that an opponent interaction of D1 and D2 neurons in the TS, modulated by dopamine, dynamically regulates avoidance and overcoming potential threats.

Intersect between brain mechanisms of conditioned threat, active avoidance, and reward

Active avoidance is a core behavior for human coping, and its excess is common across psychiatric diseases. The decision to actively avoid a threat is influenced by cost and reward. Yet, threat, avoidance, and reward have been studied in silos. We discuss behavioral and brain circuits of active avoidance and the interactions with fear and threat. In addition, we present a neural toggle switch model enabling fear-to-anxiety transition and approaching reward vs. avoiding harm decision. To fully comprehend how threat, active avoidance, and reward intersect, it is paramount to develop one shared experimental approach across phenomena and behaviors, which will ultimately allow us to better understand human behavior and pathology.

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.

Responses

Your email address will not be published. Required fields are marked *